Last updated: 11/07/2018 11:28:15

Study to assess the burden of mild outcomes (physician office visits) due to influenza in the United States

GSK study ID
117233
See study documents
Clinicaltrials.gov ID
NCT02019732
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Finalized
Finalized
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Burden of mild outcomes due to influenza in the United States, July 2000 through April 2009 and October 2010 to May 2011
Trial description: This is a database study to quantify the burden of multiple mild outcomes (i.e., those that result in visits to a physician’s office) attributable to influenza in the United States, stratified by age group, geographic region and influenza subtype for selected influenza seasons.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Weekly occurrences of potentially influenza-attributable physician’s office visits by age, region and season.

Timeframe: Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database).

Secondary outcomes:

Assessment of Influenza vaccine content and effectiveness by season.

Timeframe: Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database).

Assessment of Influenza vaccine coverage by season and region.

Timeframe: Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database).

Assessment of Influenza B vaccine mismatch (by region and season).

Timeframe: Up to 10 years approximately (Marketscan Commercial Database) and up to 6 years approximately (Marketscan Medicare Supplemental Database).

Interventions:
Other: Data collection
Enrollment:
1
Observational study model:
Other
Primary completion date:
Not applicable
Time perspective:
Retrospective
Clinical publications:
Matias G et al. (2016) Model estimates of the burden of outpatient visits attributable to influenza in the United States. BMC Infect Dis.16(1):641.
Medical condition
Influenza
Product
GSK2321138A
Collaborators
Not applicable
Study date(s)
January 2013 to June 2013
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
Not applicable
Accepts healthy volunteers
No
  • Recorded in a Marketscan database with any of the specified diagnostic codes.
  • Missing data in any of the following fields: age, diagnosis, region or visit date.
Inclusion and exclusion criteria
Inclusion criteria:

    Recorded in a Marketscan database with any of the specified diagnostic codes.

Exclusion criteria:

    Missing data in any of the following fields: age, diagnosis, region or visit date.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Bethesda, Maryland, United States, 20814
Status
Study Complete
Contact us

Study documents

Scientific result summary
Available language(s): English
Download document(s)

If you wish to request for full study report, please contact - [email protected]

Results overview

Refer to study documents

Recruitment status
Finalized
Actual primary completion date
Not applicable
Actual study completion date
2013-30-06

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website